Cite
First experience of active surveillance before systemic target therapy in patients with metastatic renal cell carcinoma
MLA
Kuniaki Itoh, et al. “First Experience of Active Surveillance before Systemic Target Therapy in Patients with Metastatic Renal Cell Carcinoma.” Urology, vol. 82, no. 1, Dec. 2012. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....74f1df0e3c2247764e382351d4d7990f&authtype=sso&custid=ns315887.
APA
Kuniaki Itoh, Yasuyuki Sakai, Nobuaki Matsubara, Yoichi Naito, Yoshinobu Komai, & Hirofumi Mukai. (2012). First experience of active surveillance before systemic target therapy in patients with metastatic renal cell carcinoma. Urology, 82(1).
Chicago
Kuniaki Itoh, Yasuyuki Sakai, Nobuaki Matsubara, Yoichi Naito, Yoshinobu Komai, and Hirofumi Mukai. 2012. “First Experience of Active Surveillance before Systemic Target Therapy in Patients with Metastatic Renal Cell Carcinoma.” Urology 82 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....74f1df0e3c2247764e382351d4d7990f&authtype=sso&custid=ns315887.